Recent surgical management of ovarian cancer

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 5, 2011, Pages 379-382

  Khoury Collado, Fady ^a   Chi, Dennis S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cytoreduction; Epithelial ovarian cancer; Ovarian cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL DISEASE; ADVANCED CANCER; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; COLON RESECTION; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; HUMAN; OVARY CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RECURRENT DISEASE; SIGMOIDOSCOPY; THORAX DISEASE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 79956106292     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01569.x     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Armstrong DK, Bundy B, Wenzel L, Gynecologic Oncology Group et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43. (Pubitemid 43048949)
3. Crawford SC, Vasey PA, Paul J, Hay A, Davis JA, Kaye SB. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international com-parison within the SCOTROC-1 Trial. J Clin Oncol 2005; 23: 8802-8811. (Pubitemid 46211526)
4. Erratum in: J Clin Oncol 2006; 24 (7): 1224.
5. Markman M. Concept of optimal surgical cytoreduction in advanced ovarian cancer: A brief critique and a call for action. J Clin Oncol 2007; 25: 4168-4170. (Pubitemid 47548554)
6. Vergote I, Tropé CG, Amant F et al. NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl JMed 2010;363:943-953.
7. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101-104.
8. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002; 20: 1248-1259. (Pubitemid 34177431)
9. Hoskins WJ, McGuire WP, Brady MF et al. The effect of diam-eter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 170: 974-979.
10. Chi DS, Liao JB, Leon LF et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 82: 532-537. (Pubitemid 32826455)
11. Chi DS, Eisenhauer EL, Lang J et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006; 103: 559-564. (Pubitemid 44602167)
12. Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekolo-gische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009; 115: 1234-1244.
13. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreduc-tive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 1998; 69: 103-108. (Pubitemid 28246994)
14. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study. Gynecol Oncol 2003; 90: 390-396. (Pubitemid 36952033)
15. Chi DS, Eisenhauer EL, Zivanovic O et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009; 114: 26-31.
16. Aletti GD, Dowdy SC, Gostout BS et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006; 107: 77-85.
17. Eisenhauer EL, Abu-Rustum NR, Sonoda Y et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 2006; 103: 1083-1090. (Pubitemid 44821338)
18. Juretzka MM, Abu-Rustum NR, Sonoda Y et al. The impact of video-assisted thoracic surgery (VATS) in patients with sus-pected advanced ovarian malignancies and pleural effusions. Gynecol Oncol 2007; 104: 670-674. (Pubitemid 46240259)
19. Diaz JP, Abu-Rustum NR, Sonoda Y et al. Video-assisted tho-racic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. Gynecol Oncol 2010; 116: 483-488.
20. Mourton SM, Temple LK, Abu-Rustum NR et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epi-thelial ovarian cancer. Gynecol Oncol 2005; 99: 608-614. (Pubitemid 41686544)
21. Obermair A, Hagenauer S, Tamandl D et al. Safety and effi-cacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001; 83: 115-120. (Pubitemid 32959887)
22. De La Cuesta RS, Goodman A, Halverson SS, Fuller AF Jr. En bloc pelvic peritoneal resection of the intraperitoneal pelvic viscera in patients with advanced epithelial ovarian cancer. Cancer J Sci Am 1996; 2: 152-157.
23. Bristow RE, Del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg 2003; 197: 565-774.
24. Hoffman MS, Zervose E. Colon resection for ovarian cancer: Intraoperative decisions. Gynecol Oncol 2008; 111: S56-S65.
25. Silver DF, Zgheib NB. Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and con-siderations. Gynecol Oncol 2009; 114: 427-430.
26. Bristow RE, Puri I, Chi DS. Cytoreductive surgery for recur-rent ovarian cancer: A meta-analysis. Gynecol Oncol 2009; 112: 265-274.
27. Chi DS, McCaughty K, Diaz JP et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939. (Pubitemid 43673208)
28. Shih KK, Chi DS, Barakat RR, Leitao MM Jr. Tertiary cytore-duction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series. Gynecol Oncol 2010; 117: 330-335.
29. Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010; 118: 262-267.